Basic Information
Telfast Oral Suspension 6 mg/ml
SUSPENSION
Regulatory Information
SIN14199P
July 20, 2012
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XR06AX26
Company Information
OPELLA HEALTHCARE SINGAPORE PTE. LTD.
OPELLA HEALTHCARE SINGAPORE PTE. LTD.
Active Ingredients
Strength: 30.00 mg/5 ml
Detailed Information
Contraindications
**CONTRAINDICATIONS** TELFAST oral suspension is contraindicated in patients with known hypersensitivity to fexofenadine and any of the ingredients of TELFAST. Rare cases of hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnea, flushing and systemic anaphylaxis have been reported.
Indication Information
**INDICATIONS AND USAGE** - **Seasonal Allergic Rhinitis** TELFAST is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. - **Chronic Idiopathic Urticaria** TELFAST is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.